| Title |
Effect of Anticholinergic Medications on Falls, Fracture Risk, and Bone Mineral Density Over a 10-Year Period
|
|---|---|
| Published in |
Annals of Pharmacotherapy, May 2014
|
| DOI | 10.1177/1060028014535363 |
| Pubmed ID | |
| Authors |
Lisa-Ann Fraser, Jonathan D. Adachi, William D. Leslie, David Goltzman, Robert Josse, Jerilynn Prior, Stephanie Kaiser, Nancy Kreiger, Christopher S. Kovacs, Tassos P. Anastassiades, Alexandra Papaioannou, David Goltzman, Nancy Kreiger, Suzanne Godmaire, Silvia Dumont, Claudie Berger, Wei Zhou, Christopher Kovacs, Emma Sheppard, Susan Kirkland, Stephanie Kaiser, Barbara Stanfield, Jacques P. Brown, Louis Bessette, Marc Gendreau, Tassos Anastassiades, Tanveer Towheed, Barbara Matthews, Bob Josse, Sophie Jamal, Tim Murray, Barbara Gardner-Bray, Jonathan D. Adachi, Alexandra Papaioannou, Laura Pickard, P. Olszynski, K. Shawn Davison, Jola Thingvold, David A. Hanley, Jane Allan, Jerilynn C. Prior, Millan Patel, Yvette Vigna, Brian Lentle |
| Abstract |
Many medications used in older adults have strong anticholinergic (ACH) properties, which may increase the risk of falls and fractures. Use of these medications was identified in a population-based Canadian cohort. |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 22% |
| Canada | 1 | 11% |
| Japan | 1 | 11% |
| Unknown | 5 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 67% |
| Practitioners (doctors, other healthcare professionals) | 3 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 45 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 8 | 18% |
| Researcher | 8 | 18% |
| Student > Bachelor | 6 | 13% |
| Student > Master | 5 | 11% |
| Student > Ph. D. Student | 3 | 7% |
| Other | 9 | 20% |
| Unknown | 6 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 36% |
| Nursing and Health Professions | 8 | 18% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 11% |
| Social Sciences | 2 | 4% |
| Neuroscience | 2 | 4% |
| Other | 2 | 4% |
| Unknown | 10 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 June 2016.
All research outputs
#5,667,006
of 22,755,127 outputs
Outputs from Annals of Pharmacotherapy
#962
of 3,212 outputs
Outputs of similar age
#53,408
of 227,219 outputs
Outputs of similar age from Annals of Pharmacotherapy
#16
of 70 outputs
Altmetric has tracked 22,755,127 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,212 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,219 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.